Incidence of Airway-Related Complications in Sedation-Assisted Transcatheter Aortic Valve Implantation Using High-Flow Oxygen Therapy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1032250469

Enrollment

Registered

2025-10-30

Start date

2025-10-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic valve stenosis High-flow oxygen therapy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients undergoing transcatheter aortic valve implantation under sedation 2) Patients aged 18 years or older at the time of surgery 3) Patients with an American Society of Anesthesiologists (ASA) physical status classification of Class 3 Class 3: Patients with severe systemic disease (e.g., poorly controlled hypertension or diabetes, chronic obstructive pulmonary disease, severe obesity, cardiac dysfunction, end-stage renal failure) 4) Patients for whom consent for participation in this study can be obtained from the patient or a legal representative

Exclusion criteria

Exclusion criteria: 1) Patients undergoing emergency surgery 2) Patients who may be pregnant 3) Patients with a body mass index (BMI) of 35 or higher 4) Patients with a history of upper airway surgery

Design outcomes

Primary

Measure	Time frame
Incidence of upper airway obstruction	—

Secondary

Measure	Time frame
Incidence of hypoxemia Names and doses of sedatives and opioid analgesics Frequency of temporary interruptions in surgery due to tracheal intubation, etc.	—

Contacts

Public ContactHidetoshi Nagayama

Dokkyo Medical U niversity Saitama Medical Center

h-nagayama@dokkyomed.ac.jp+81-489651111

Outcome results